---
title: Clario vs Genelife Clinical Research Pvt. Ltd.
slug_a: clario
slug_b: genelifecr
site: cro
review_signal_gate: closed
canonical_path: /compare/clario/genelifecr
---

# Clario vs Genelife Clinical Research Pvt. Ltd.

Side-by-side profile data from each company listing on this directory.

## Clario

- Profile: [/companies/clario](/companies/clario)

Clario — Clario provides comprehensive clinical trial endpoint solutions spanning cardiac safety, eCOA, medical imaging, respiratory, and precision motion analysis, supporting approximately 70% of FDA and EMA novel drug approvals over the past decade.

Services: 16. Modalities: 4. Indications: 12. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (16).

### Services

- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Medical Writing
- Central Laboratory Services
- Clinical Imaging Core Lab
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- CNS Specialty Services
- Cardiovascular & Metabolic Specialty Services

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Vaccine

### Indications

- Oncology
- Immunology
- Neurology
- Metabolic
- Cardiovascular
- Infectious Disease
- Rare Disease
- Respiratory
- Dermatology
- Ophthalmology
- Gastroenterology
- Women's Health

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)

## Genelife Clinical Research Pvt. Ltd.

- Profile: [/companies/genelifecr](/companies/genelifecr)

Genelife Clinical Research Pvt. Ltd. — CDSCO-registered CRO in India running Phase I–IV trials, real world evidence studies, and bioequivalence (BABE) studies for pharma, biotech, and device sponsors. Offices in Mumbai, California, Cambridge, and Hamburg support multi-regional programs.

Services: 13. Modalities: 4. Indications: 4. Locations: 4. Certifications: 1. The strongest documented coverage currently appears in services (13).

### Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Central Laboratory Services
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy

### Modalities

- Small Molecule
- Biologics (Other)
- Peptide
- Vaccine

### Indications

- Oncology
- Neurology
- Cardiovascular
- Dermatology

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV
- Real-World Evidence (RWE) / Registries

### Sourcing models

- Full-Service Outsourcing (FSO)